Children as young as six become focus of weight-loss drug research

Researchers are investigating whether GLP-1 weight-loss medicines – like Ozempic – could help children with obesity ‘become healthier’, but the prospect of treating younger patients has raised questions about the safety and long-term effects of such a radical plan.